@Lisa_Callahan_ Profile picture

Lisa Callahan

@Lisa_Callahan_

Similar User
Kamal Thippu MD FRCR photo

@KamalThippu

Dr. Caitlin McMullen photo

@mcmullen_dr

AHernando_Calvo photo

@AhernandoCalvo

Biofidelity photo

@biofidelity_dx

Karen Molan photo

@KarenMolan

Dr.Vimoj J. Nair MBBS MD MSc FRCPC photo

@drvimojnair

adam nowlan, md, mph photo

@adamnowlan

Peter Zeng photo

@peteryufanzeng

Lisa Callahan Reposted

Today #CCTG recognizes myelodysplastic syndromes Day #MDSWAD2024 & stand with friends, supporters & advocates to raise awareness of the needs & challenges of the #MDS community. Find out more about #MDS research in Canada: buff.ly/4fjaiFF #United4MDS

Tweet Image 1

Lisa Callahan Reposted

The National Institutes of Health @NIH has launched myeloMATCH a precision medicine study that aims to match #AML and #MDS patients to treatments based on the genetics of their cancer. #CancerMoonshot buff.ly/4faCknb

Tweet Image 1

Lisa Callahan Reposted

#BloodCancerAwarenessMonth - A CCTG trial spotlight: HD11 a #Hodgkin #Lymphoma trial comparing a number of new agents to the standard treatment for patients who relapsed or did not respond to prior treatment. ctg.queensu.ca/patients/hodgk…

Tweet Image 1

Lisa Callahan Reposted

Today is #CancerResearchDay! #CCTG honors the brilliant and hardworking minds behind advancements in cancer research. Your passion and persistence drive the breakthroughs that save lives. Thank you for everything you do. #CancerResearch #ClinicalTrials #SolvingCancerTogether

Tweet Image 1

Lisa Callahan Reposted

.#AGITG #TOPGEAR (#CCTG GA1) results presented at #ESMO24 & simultaneously published in NEJM. Researchers investigated adding concurrent radiotherapy to standard treatment to determine if it would improve response rates and ultimately overall survival. bit.ly/4d13gDS

Tweet Image 1
Tweet Image 2

Lisa Callahan Reposted

#ESMO24 #CCTG BR31 tested the benefit of receiving adjuvant immunotherapy with durvalumab after tumour resection in early-stage non-small cell lung cancer. The study did not meet its primary endpoint of a significant improvement in disease free survival. bit.ly/3ML0NCQ

Tweet Image 1

Lisa Callahan Reposted

#CCTG HE1 trial @TheLancetOncol publication shows that palliative radiation improves pain management for liver cancer patients and should be a standard palliative intervention. Congrats to @ldawsonmd @UHN @pmcancercentre thx to @CCSResearch @cancersociety bit.ly/4dQvP81


Lisa Callahan Reposted

Join us in welcoming our newest patient representative, Carol Hill, to #CCTG. Carol is a retired educator and breast cancer survivor who will be supporting the IND program with her valuable knowledge and insights. #CancerResearch bit.ly/4cubdSw

Tweet Image 1

Lisa Callahan Reposted

#CCTG’s new study SC29 explores a new approach in #CancerTreatment. The study aims to determine whether Stereotactic Body Radiation Therapy (#SBRT) offers patients superior pain relief compared to Conventional Radiation Therapy (#CRT). #ClinicalTrials bit.ly/3XNwIZU

Tweet Image 1

Lisa Callahan Reposted

Our new project, CAN-PIVOT, is designed to further understand the factors influencing cancers to resist #immunotherapy. Led by Dr. Anna Spreafico, the project team will use funding to generate data and collect information to help advance immunotherapy. bit.ly/3xo6CSB

Tweet Image 1

Lisa Callahan Reposted

We’re very excited about this news for @CDNCancerTrials, a national program of @cancersociety This new partnership will support 3 clinical trials that aim to make immunotherapy more effective for people with cancer.

The Canadian Cancer Trials Group (#CCTG) is joining forces with @marathonofhope (#MOHCCN) to conduct three pan-Canadian projects with the goal of increasing the effectiveness of #immunotherapy for cancer patients. #CancerResearch #ClinicalTrials bit.ly/4cvVlPb

Tweet Image 1


Lisa Callahan Reposted

In recognition of #pride month when 2SLGBTQI+ communities and allies come together to spotlight the resilience, celebrate the talent, and recognize the contributions of 2SLGBTQI+ communities. Our #CCTG Trialblazer team is ready for another #YGK @KingstonPride parade!

Tweet Image 1

Lisa Callahan Reposted

The Canadian Cancer Trials Group (#CCTG) is joining forces with @marathonofhope (#MOHCCN) to conduct three pan-Canadian projects with the goal of increasing the effectiveness of #immunotherapy for cancer patients. #CancerResearch #ClinicalTrials bit.ly/4cvVlPb

Tweet Image 1

Lisa Callahan Reposted

#CCTG & @marathonofhope are excited to launch CAN-PREDICT-IT. The project aims to better predict which cancer patients will benefit from specific #immunotherapies by using large data sets from patients to identify significant biomarkers. #ClinicalTrials bit.ly/3z8oOQC

Tweet Image 1

Lisa Callahan Reposted

New Queen's-supported research indicates a groundbreaking shift in cancer care. Findings published in the @NEJM reveal that a simple hysterectomy is an effective treatment option for low-risk, early-stage #CervicalCancer patients. The #ClinicalTrial, led by @CDNCancerTrials at…

Tweet Image 1

Lisa Callahan Reposted

Less invasive hysterectomy an option for some cervical cancer patients, study says cp24.com/lifestyle/less…


Lisa Callahan Reposted

Trial Spotlight - #CCTG MY13 is a new multiple myeloma trial assessing the timing of treatment injections and has now opened in Canada. #WorldCancerDay #CloseTheCareGap #SolvingCancerTogether bit.ly/3Ou0ZHM

Tweet Image 1

Lisa Callahan Reposted

#CCTG IND227 trial results published in @TheLancet concludes that the addition of pembrolizumab to platinum–pemetrexed improved overall survival in patients with #pleural #mesothelioma thelancet.com/journals/lance…

Tweet Image 1

Lisa Callahan Reposted

A well deserved honour @Philippe_Bedard! Dr Bedard was the former #CCTG IND chair and current member of breast of our Breast Disease Site executive.

Congratulations Philippe! Thank you for all your past and current contributions to the IND Program.

Tweet Image 1


Loading...

Something went wrong.


Something went wrong.